Aortic collagen, aortic stiffness, and AT1 receptors in experimental and human hypertension

Canadian Journal of Physiology and Pharmacology

Volumn 74, Issue 7, 1996, Pages 862-866

  Benetos, A ^a   Safar, M E ^a  

^a HÔPITAL BROUSSAIS   (France)

Author keywords

Aortic stiffness; Collagen of the arterial wall; Hypertension; Renin angiotensin system inhibition

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; QUINAPRIL;

ARTERY WALL; CONFERENCE PAPER; GENETIC POLYMORPHISM; HUMAN; HYPERTENSION; PATHOGENESIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RIGIDITY;

EID: 0030455244     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y96-079     Document Type: Conference Paper

References (32)

1. Albaladejo, P., Bouaziz, H., Duriez, M., Gohlke, P., Levy, B.I., Safar, M.E., and Benetos, A. 1994. Angiotensin converting enzyme inhibition prevents the increase in aortic collagen in rats. Hypertension (Dallas), 23: 74-82.
2. Avolio, A.P. 1991. Pulse wave velocity and hypertension. In Arterial and venous systems in essential hypertension. Edited by M. Safar. Martinus Nijhoff Publishers, The Hague. pp. 133-152.
3. Benetos, A., Levy, B.I., Albaladejo, P., and Safar, M.E. 1995a. Role of angiotensin II and bradykinin in the arterial effects of angiotensin converting enzyme inhibition in SHRs. American Society of Hypertension, New York. (Abstr.)
4. Benetos, A., Topouchian, J., Ricard, S., Gautier, S., Bonnardeaux, A., Asmar, R., Safar, M., and Cambien, F. 1995b. Influence of angiotensin II type 1 receptor polymorphism on aortic stiffness in never-treated hypertensive patients. Hypertension (Dallas), 26: 44-47.
5. Bevan, R.D. 1975. Effect of sympathetic denervation on smooth muscle cell proliferation in the growing rabbit ear artery. Circ. Res. 37: 14-19.
6. Bonnardeaux, A., Davies, E., Jeunemaître, X., Fery, I., Charru, A., Clauser, E., Tiret, L., Cambien, F., Corvol, P., and Soubrier, F. 1994. Angiotensin II type 1 receptor gene polymorphism in human essential hypertension. Hypertension (Dallas), 24: 63-69.
7. Bunkenburg, B., Van Amelswoort, T., Rogg, H., and Wood, J.M. 1992. Receptor-mediated effects of angiotensin II on growth of vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension (Dallas), 20: 746-754.
8. Campbell, D.J. 1987. Tissue renin-angiotensin system: sites of angiotensin formation. J. Cardiovasc. Pharmacol. 10(Suppl. 7): S1-S8.
9. Christensen, K.L. 1991. Reducing pulse pressure in hypertension may normalize small artery structure. Hypertension (Dallas), 18: 722-727.
10. Christensen, K.L., Jespersen, L.T., and Mulvany, M.J. 1989. Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure. J. Hypertens. 7: 83-90.
11. Dzau, V.J., and Safar, M.E. 1977. Large conduit arteries in hypertension: role of the renin-angiotensin system. Circulation, 77: 947-953.
12. Folkow, B., Hallback, M., Lundgren, R., Sivertsson, R., and Weiss, L. 1973. Importance of adaptive changes in vascular design for establishment of primary hypertension, studied in man, and in spontaneously hypertensive rats. Circ. Res. 32-33(Suppl. I): I-2-I-16.
13. Freslon, J.L., and Giudicelli, J.G. 1983. Compared myocardial and vascular effects of captopril and dihydralazine during hypertension development in spontaneously hypertensive rats. Br. J. Pharmacol. 80: 853-563.
14. Geisterfer, A.A.T., Peach, M.J., and Owens, G.K. 1988. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ. Res. 62: 749-756.
15. Gohlke, P., Bunning, P., and Unger, T. 1992. Distribution and metabolism of angiotensin I and II in the blood vessel wall. Hypertension (Dallas), 20: 151-157.
16. Griffin, S.A., Brown, W.C.B., MacPherson, F., MacGrath, J.C., Wilson, V.G., Korsgaard, N., Mulvany, M.J., and Lever, A.F. 1991. Angiotensin II causes vascular hypertrophy in part by a nonpressor mechanism. Hypertension (Dallas), 17: 626-635.
17. Kaplan, H.R., Taylor, D.G., Olson, S.C., and Andrews, L.K. 1989. Quinapril: a preclinical review of the pharmacology, pharmacokinetics and toxicology. Angiology, 40: 335-350.
18. Kato, H., Suzuki, H., Tajima, S., Ogata, Y., Taminaga, T., Sato, A., and Saruka, T. 1991. Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J. Hypertens. 9: 17-22.
19. Keeley, F.W., Elmoselhi, A., and Leenen, F.H.H. 1992. Enalapril suppresses normal accumulation of elastin and collagen in cardiovascular tissues of growing rats. Am. J. Physiol. 262: H1013-H1021.
20. Leung, D.Y.M.P., Glagov, S., and Mathews, M.B. 1976. Cyclic stretching stimulates synthesis of matrix components by arterial smooth muscle cells in vitro. Science (Washington, D.C.), 191: 475-477.
21. Levy, B.I., Michel, J.B., Salzmann, J.L., Azizi, M., Poitevin, P., Safar, M., and Camilleri, J.P. 1988. Effects of chronic inhibition of converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension. Circ. Res. 63: 227-239.
22. Linz, W., and Sholkens, B.A. 1992. A specific B2-bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril. Br. J. Pharmacol. 105: 771-772.
23. Linz, W., Scholkens, B.A., and Ganten, D. 1989. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin. Exp. Hypertens. Part A, Theory Pract. 11: 1325-1350.
24. London, G., Marchais, S., Safar, M., Genest, A., Guérin, A., and Metivier, F. 1990. Aortic and large artery compliance in end-stage renal failure. Kidney Int. 37: 137-142.
25. Mulvany, M.J., Hansen, P.K., and Aalkjaer, C. 1982. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ. Res. 43: 854-864.
26. Naftilan, A.J., Pratt, R.E., and Dzau, V.J. 1989. Induction of c-fos, c-myc and PDGF A chain gene expression by angiotensin II in cultured rat vascular smooth muscle cells. J. Clin. Invest. 83: 1419-1424.
27. Powell, J.S., Closel, J.P., Muller, R.K.M., Kuhn, H., Hefti, F., Hosang, M., and Baumgartner, H.R. 1989. Inhibitors of angiotensin converting enzyme prevent myointimal proliferation after vascular injury. Science (Washington, D.C.), 245: 186-188.
28. Richer, C., Mulder, P., Fornes, P., Richard, V., Camilleri, J.P., and Giudicelli, J.F. 1991. Hemodynamic and morphological effects of quinapril during genetic hypertension development. J. Cardiovasc. Pharmacol. 18: 631-642.
29. Warshaw, D.M., Root, D.T., and Halpera, W. 1980. Effects of antihypertensive drug therapy on the morphology and mechanics of resistance arteries from spontaneously hypertensive rats. Blood Vessels, 17: 257-270.
30. Wiener, J., Loud, A.V., Giacomelli, F., and Anversa, P. 1977. Morphometric analysis of hypertension induced hypertrophy of rat thoracic aorta. Am. J. Pathol. 88: 619-634.
31. Wolinsky, H. 1971. Response of the rat aortic media to hypertension: morphological and chemical studies. Circ. Res. 26: 507-522.
32. Wolinsky, H. 1972. Long term effects of hypertension on the rat aortic wall and their relation to concurrent aging changes. Circ. Res.30: 301-309.